The Independent Action Model for Cancer Drug Combination Activity: Why Preclinical Combination Models are Failing at an Unprecedented Rate in the Clinic

Time: 9:45 am
day: Day One


• Highlighting the need for clear rationales to develop combination therapies

• Exploring the importance of defining synergy to reduce the failure rates of current clinical trials